It is World Statistics Day on 20th October, and we would like to highlight how effective biometric support is rising as a top strategic priority for running efficient clinical trials.
October is breast cancer awareness month, and Navitas Life Sciences continues to RISE consistently to the unique needs of oncology patients.
Technology led Navitas Life Sciences amped-up digital initiatives, especially during the pandemic, with the inclusion of innovation, creating fertile
There was a considerable change in the clinical trial landscape at the onset of the global epidemic, with the initiation of multiple COVID-19 clinical trials
Navitas Life Sciences joins the National Coordination Centre, Indian Pharmacopoeia Commission in celebrating National Pharmacovigilance week 17-23rd September 2021.
Here is how Navitas Life Sciences Defines Key Aspects on Building a resilient Future
Dr. Manish Harsh, Vice President, Clinical data Services provides key insights about the impact of technology on efficient clinical data management
A Market Authorization Holder (MAH) appoints a Qualified Person responsible for Pharmacovigilance (QPPV) to market drug products in the European Union (EU)...
Regulatory Affairs play a pivotal role in bringing new drug products to the market swiftly. However, it is often perceived
In the everchanging clinical trial landscape, a sustainable quality management system is imperative. The Pharmaceutical Quality for the 21st Century